Mark Price, MA, MEd, is an Executive Director of Surveys and Observational Studies, where he works on both qualitative and quantitative tasks associated with prospective observational and survey studies designed to gather real-world evidence in support of his clients’ strategic initiatives. Mr. Price has designed, led, or supported numerous burden-of-illness studies centered on collecting patient-reported outcomes, functional assessment, and medical record data to support the development of economic models, outcomes research, and market access initiatives for industry clients. These studies have entailed leadership and coordination with multidisciplinary teams of key opinion leaders, health economists, epidemiologists, patient-reported outcomes experts, clinical research associates, survey development experts, and biostatisticians. Mr. Price has more than 25 years of experience in the design, collection, analysis, interpretation, and reporting of real-world data. Mr. Price has designed, coordinated, and analyzed data for studies in the specific disease areas of cardiovascular disorders, endocrinal disorders, gastrointestinal disorders, human immunodeficiency virus, male sexual dysfunction, neurological and neuromuscular disorders (including multiple sclerosis and sporadic inclusion body myositis), obesity and dyslipidemia, oncology (including prostate cancer, melanoma, and non-small cell lung cancer), psychiatric disorders (including depression and schizophrenia), and respiratory disorders. Mr. Price’s areas of expertise include both qualitative and quantitative research design and methodology (focus groups, patient interviews, survey development, online data collection), coordination and management of large scale, multinational cross-sectional and longitudinal studies, risk-minimization evaluations, statistical analysis, psychometrics, and technical writing and editing. He has experience with statistical analysis, qualitative data analysis, and database programs. Mr. Price’s research is regularly presented and published in a wide variety of venues, and he is a regular peer reviewer for several clinical and methodological journals. His language skills include fluency in French and an intermediate knowledge of Spanish, and he has designed parallel bilingual data-collection protocols.